Suppr超能文献

83884例经颈静脉肝内门体分流术患者住院死亡率的全国趋势及预测因素

Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.

作者信息

Lee Edward Wolfgang, Kuei Andrew, Saab Sammy, Busuttil Ronald W, Durazo Francisco, Han Steven-Huy, El-Kabany Mohamed M, McWilliams Justin P, Kee Stephen T

机构信息

Edward Wolfgang Lee, Andrew Kuei, Justin P McWilliams, Stephen T Kee, Department of Radiology, Division of Interventional Radiology, Ronald Reagan Medical Center at UCLA, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States.

出版信息

World J Gastroenterol. 2016 Jul 7;22(25):5780-9. doi: 10.3748/wjg.v22.i25.5780.

Abstract

AIM

To evaluate and validate the national trends and predictors of in-patient mortality of transjugular intrahepatic portosystemic shunt (TIPS) in 15 years.

METHODS

Using the National Inpatient Sample which is a part of Health Cost and Utilization Project, we identified a discharge-weighted national estimate of 83884 TIPS procedures performed in the United States from 1998 to 2012 using international classification of diseases-9 procedural code 39.1. The demographic, hospital and co-morbility data were analyzed using a multivariant analysis. Using multi-nominal logistic regression analysis, we determined predictive factors related to increases in-hospital mortality. Comorbidity measures are in accordance to the Comorbidity Software designed by the Agency for Healthcare Research and Quality.

RESULTS

Overall, 12.3% of patients died during hospitalization with downward trend in-hospital mortality with the mean length of stay of 10.8 ± 13.1 d. Notable, African American patients (OR = 1.809 vs Caucasian patients, P < 0.001), transferred patients (OR = 1.347 vs non-transferred, P < 0.001), emergency admissions (OR = 3.032 vs elective cases, P < 0.001), patients in the Northeast region (OR = 1.449 vs West, P < 0.001) had significantly higher odds of in-hospital mortality. Number of diagnoses and number of procedures showed positive correlations with in-hospital death (OR = 1.249 per one increase in number of procedures). Patients diagnosed with acute respiratory failure (OR = 8.246), acute kidney failure (OR = 4.359), hepatic encephalopathy (OR = 2.217) and esophageal variceal bleeding (OR = 2.187) were at considerably higher odds of in-hospital death compared with ascites (OR = 0.136, P < 0.001). Comorbidity measures with the highest odds of in-hospital death were fluid and electrolyte disorders (OR = 2.823), coagulopathy (OR = 2.016), and lymphoma (OR = 1.842).

CONCLUSION

The overall mortality of the TIPS procedure is steadily decreasing, though the length of stay has remained relatively constant. Specific patient ethnicity, location, transfer status, primary diagnosis and comorbidities correlate with increased odds of TIPS in-hospital death.

摘要

目的

评估并验证15年来经颈静脉肝内门体分流术(TIPS)住院死亡率的全国趋势及预测因素。

方法

利用作为医疗成本和利用项目一部分的全国住院患者样本,我们使用国际疾病分类第九版手术编码39.1,确定了1998年至2012年在美国进行的83884例TIPS手术的出院加权全国估计数。使用多变量分析对人口统计学、医院和合并症数据进行分析。通过多项逻辑回归分析,我们确定了与住院死亡率增加相关的预测因素。合并症测量符合医疗保健研究与质量局设计的合并症软件。

结果

总体而言,12.3%的患者在住院期间死亡,住院死亡率呈下降趋势,平均住院时间为10.8±13.1天。值得注意的是,非裔美国患者(与白人患者相比,比值比=1.809,P<0.001)、转院患者(与未转院患者相比,比值比=1.347,P<0.001)、急诊入院患者(与择期病例相比,比值比=3.032,P<0.001)、东北地区患者(与西部地区相比,比值比=1.449,P<0.001)的住院死亡率显著更高。诊断数量和手术数量与住院死亡呈正相关(手术数量每增加一个,比值比=1.249)。与腹水患者相比(比值比=0.136,P<0.001),诊断为急性呼吸衰竭(比值比=8.246)、急性肾衰竭(比值比=4.359)、肝性脑病(比值比=2.217)和食管静脉曲张破裂出血(比值比=2.187)的患者住院死亡几率明显更高。住院死亡几率最高的合并症测量指标是液体和电解质紊乱(比值比=2.823)、凝血病(比值比=2.016)和淋巴瘤(比值比=1.842)。

结论

TIPS手术的总体死亡率在稳步下降,尽管住院时间相对保持不变。特定的患者种族、位置、转院状态、主要诊断和合并症与TIPS住院死亡几率增加相关。

相似文献

1
Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.
World J Gastroenterol. 2016 Jul 7;22(25):5780-9. doi: 10.3748/wjg.v22.i25.5780.
2
Inpatient Cost Assessment of Transjugular Intrahepatic Portosystemic Shunt in the USA from 2001 to 2012.
Dig Dis Sci. 2016 Oct;61(10):2838-2846. doi: 10.1007/s10620-016-4233-z. Epub 2016 Jun 27.
3
National Trends and Outcomes of Transjugular Intrahepatic Portosystemic Shunt Creation Using the Nationwide Inpatient Sample.
J Vasc Interv Radiol. 2016 Jun;27(6):838-45. doi: 10.1016/j.jvir.2015.12.013. Epub 2016 Mar 7.
5
Portosystemic Shunts: Stable Utilization and Improved Outcomes, Two Decades After the Transjugular Intrahepatic Portosystemic Shunt.
J Am Coll Radiol. 2015 Dec;12(12 Pt B):1427-33. doi: 10.1016/j.jacr.2015.06.037. Epub 2015 Sep 26.
8
Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
J Gastroenterol Hepatol. 2005 Mar;20(3):474-81. doi: 10.1111/j.1440-1746.2005.03601.x.
9
Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Cochrane Database Syst Rev. 2018 Oct 31;10(10):CD001023. doi: 10.1002/14651858.CD001023.pub3.

引用本文的文献

2
Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessment.
Comput Struct Biotechnol J. 2024 Jul 10;24:493-506. doi: 10.1016/j.csbj.2024.07.008. eCollection 2024 Dec.
5
Frailty as a risk-stratification tool in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS).
J Frailty Sarcopenia Falls. 2023 Jun 1;8(2):83-93. doi: 10.22540/JFSF-08-083. eCollection 2023 Jun.
6
Transjugular Intrahepatic Portosystemic Shunt Outcomes in the Elderly Population: A Systematic Review and Meta-Analysis.
Gastroenterology Res. 2022 Dec;15(6):325-333. doi: 10.14740/gr1571. Epub 2022 Dec 1.
7
Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes.
BMJ Open Gastroenterol. 2022 Jan;9(1). doi: 10.1136/bmjgast-2021-000747.
8
Transjugular Portosystemic Stent Shunt: Impact of Right Atrial Pressure on Portal Venous Hemodynamics Within the First Week.
Cardiovasc Intervent Radiol. 2022 Jan;45(1):102-111. doi: 10.1007/s00270-021-03003-z. Epub 2021 Dec 1.
10
Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement.
J Gastroenterol Hepatol. 2021 Mar;36(3):775-781. doi: 10.1111/jgh.15194. Epub 2020 Sep 8.

本文引用的文献

2
Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical Outcomes.
Dig Dis Sci. 2015 Apr;60(4):1059-66. doi: 10.1007/s10620-014-3391-0. Epub 2014 Oct 15.
3
The history and future of transjugular intrahepatic portosystemic shunt: food for thought.
Semin Intervent Radiol. 2014 Sep;31(3):258-61. doi: 10.1055/s-0034-1382794.
4
Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data.
Clin Mol Hepatol. 2014 Mar;20(1):18-27. doi: 10.3350/cmh.2014.20.1.18. Epub 2014 Mar 26.
6
Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.
World J Gastroenterol. 2012 Oct 7;18(37):5211-8. doi: 10.3748/wjg.v18.i37.5211.
7
The evaluation of the patient undergoing an elective transjugular intrahepatic portosystemic shunt procedure.
Semin Intervent Radiol. 2005 Dec;22(4):266-70. doi: 10.1055/s-2005-925552.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验